[18F]-T807 PET/CT Imaging of Tau Pathology in Young Onset Focal Dementia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Jan 2018
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Dementia; Primary progressive aphasia
- Focus Diagnostic use
- 24 Jan 2018 Planned End Date changed from 1 Dec 2018 to 31 Jan 2019.
- 24 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 10 Jun 2017 Biomarkers information updated